M&T Bank Corp increased its holdings in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) by 33.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,680 shares of the company’s stock after purchasing an additional 5,205 shares during the period. M&T Bank Corp’s holdings in Acadia Healthcare were worth $723,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. LPL Financial LLC lifted its stake in Acadia Healthcare by 13.8% in the second quarter. LPL Financial LLC now owns 12,945 shares of the company’s stock valued at $452,000 after buying an additional 1,568 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of Acadia Healthcare by 3.5% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 705,018 shares of the company’s stock valued at $24,641,000 after acquiring an additional 23,676 shares in the last quarter. MUFG Americas Holdings Corp lifted its position in shares of Acadia Healthcare by 127.4% during the 2nd quarter. MUFG Americas Holdings Corp now owns 1,294 shares of the company’s stock valued at $45,000 after acquiring an additional 725 shares during the period. Oppenheimer Asset Management Inc. lifted its position in shares of Acadia Healthcare by 24.7% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 22,214 shares of the company’s stock valued at $777,000 after acquiring an additional 4,395 shares during the period. Finally, Jennison Associates LLC boosted its stake in Acadia Healthcare by 15.5% during the second quarter. Jennison Associates LLC now owns 610,991 shares of the company’s stock worth $21,354,000 after acquiring an additional 81,966 shares in the last quarter.

ACHC stock traded up $0.97 during midday trading on Wednesday, reaching $31.40. 22,189 shares of the company’s stock traded hands, compared to its average volume of 690,942. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.53. The firm’s fifty day moving average price is $28.50 and its 200-day moving average price is $30.92. Acadia Healthcare Company Inc has a 52 week low of $24.27 and a 52 week high of $45.35. The company has a market cap of $2.56 billion, a price-to-earnings ratio of 13.98, a P/E/G ratio of 1.28 and a beta of 0.71.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.02. The firm had revenue of $789.00 million during the quarter, compared to analysts’ expectations of $795.31 million. Acadia Healthcare had a negative net margin of 6.80% and a positive return on equity of 7.20%. The business’s revenue was up 3.0% on a year-over-year basis. During the same period last year, the company earned $0.70 earnings per share. Analysts forecast that Acadia Healthcare Company Inc will post 2.14 earnings per share for the current year.

A number of equities research analysts have commented on the stock. TheStreet upgraded shares of Acadia Healthcare from a “d+” rating to a “c” rating in a report on Monday, June 17th. UBS Group cut their price objective on shares of Acadia Healthcare from $30.00 to $29.00 and set a “neutral” rating on the stock in a research report on Friday, September 6th. Zacks Investment Research cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 price objective on the stock. in a research report on Wednesday, August 7th. Mizuho set a $30.00 target price on Acadia Healthcare and gave the company a “hold” rating in a research note on Friday, May 31st. Finally, Raymond James lowered Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 target price for the company. in a research report on Wednesday, July 31st. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $36.00.

In other Acadia Healthcare news, CEO Debra K. Osteen purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The shares were acquired at an average price of $26.53 per share, with a total value of $530,600.00. Following the transaction, the chief executive officer now owns 117,178 shares in the company, valued at $3,108,732.34. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.60% of the stock is currently owned by company insiders.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

See Also: How does a security become overbought?

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.